Галерея 3114848

Галерея 3114848

Did this number call you too?
No
Yes, called

Show all comments
Let me know when you find out who this phone number belongs to!

866 3220484 via Verizon call filters
03-09-2023 :
Skytel wireless

via .. 888 4700655 This is a scam. Claimed to be AT&T collections and called me but .. 559 3820893 Not a spam number but a police that will put you in jail or bette.. 510 3454126 SCAM robocall.. 631 6580029 SCAM robocall.. 855 9930303 In Canada, I answered and women wanted to know if I was looking t.. 902 3340365 Called back as another site said it has continued to call people .. 650 8721815 Melissa Oligario is a robocall SCAMMER.. 877 3114939 This number called to ask that I donate to a Police association. .. 417 3130520 Spam.... 732 9032849 Spam.... 248 3521640 Spam.... 406 2131250 Spam.... 786 7066467 Spam.... 281 8849622 Spam....
+1 8773114848 Whose? Where does it belong? Who is the owner?
877-311-4848 information on the phone number is available on this page. Did this 8773114848 number call you too?
The representation of the (877) 311-4848 number on this page does not mean that this number is Dangerous. No ratings has been made yet.
877 3114848 telephone number was registered to our Unknown Number Inquiry Service on 2022-11-04 and was searched 131 times .
Numbers starting with 877 are locationless special numbers that are not registered with a real operator. They can call via internet based system or call centers. This number service is registered as Toll Free .
Comments on (877) 311-4848 phone number will help people called by this number. Last call, someone else searched this number 9 days ago . A total of 131 called with you.
Did this number call you too? Please write your comment without insulting or sharing personal information.
This page has been created to provide information about tel:8773114848 phone number and provides completely free service. If there is inappropriate content on this page, please contact us. If you are also called by this number, you can let more people get information by writing a comment.It is aimed to convey complaints to phone owners and to protect other users by informing the callers by +18773114848 phone number. With real user comments and reviews, you can find answers to all your questions about where 0018773114848, who belongs to, and the reason for the search.
Disclaimer: Tel-No 's mission is to give people easy access to public record information. Comments on our website are for informational purposes only and belong to the site users. Our site cannot be held responsible for phone numbers and comments.

Неверное перенаправление на странице

Эта проблема может возникать при отключении или запрещении принятия кук.

Firefox определил, что сервер перенаправляет запрос на этот адрес таким образом, что он никогда не завершится.

Отправка сообщений о подобных ошибках поможет Mozilla обнаружить и заблокировать вредоносные сайты

Сообщить
Попробовать снова
Отправка сообщения
Сообщение отправлено

использует защитную технологию, которая является устаревшей и уязвимой для атаки. Злоумышленник может легко выявить информацию, которая, как вы думали, находится в безопасности.

Clipboard, Search History, and several other advanced features are temporarily unavailable.

Dashboard
Publications
Account settings
Log out

Advanced

Clipboard

Format

Abstract

PubMed

PMID

Format:

Summary (text)
PubMed
PMID
Abstract (text)
CSV

Subject:

1 selected item: 3114848 - PubMed

Format:

Summary
Summary (text)
Abstract
Abstract (text)

Create a new collection

Add to an existing collection

Name must be less than 100 characters

Unable to load your collection due to an error
Please try again

Unable to load your delegates due to an error
Please try again

Would you like email updates of new search results?

Saved Search Alert Radio Buttons

Yes

No

Frequency:

Monthly
Weekly
Daily

Which day?

The first Sunday
The first Monday
The first Tuesday
The first Wednesday
The first Thursday
The first Friday
The first Saturday
The first day
The first weekday

Which day?

Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday

Report format:

Summary
Summary (text)
Abstract
Abstract (text)
PubMed

Send at most:

1 item
5 items
10 items
20 items
50 items
100 items
200 items

Send even when there aren't any new results

Number of items displayed:

5
10
15
20
50
100

Create a new collection Add to an existing collection

Name must be less than 100 characters

Unable to load your collection due to an error Please try again

Page navigation

Title & authors

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

A Uggla et al.

Res Vet Sci .

1987 Jul .

Format

Abstract

PubMed

PMID

Dubey JP, Andrews CD, Lind P, Kwok OC, Thulliez P, Lunney JK.
Dubey JP, et al.
Am J Vet Res. 1996 Dec;57(12):1733-7.
Am J Vet Res. 1996.

PMID: 8950427

Dubey JP, Desmonts G, McDonald C, Walls KW.
Dubey JP, et al.
Am J Vet Res. 1985 May;46(5):1085-8.
Am J Vet Res. 1985.

PMID: 4003883

Costa AJ, Araujo FG, Costa JO, Lima JD, Nascimento E.
Costa AJ, et al.
J Parasitol. 1977 Apr;63(2):212-8.
J Parasitol. 1977.

PMID: 558305

Buxton D.
Buxton D.
Vet Res. 1998 May-Aug;29(3-4):289-310.
Vet Res. 1998.

PMID: 9689743

Review.

Piergili Fioretti D.
Piergili Fioretti D.
Parassitologia. 2004 Jun;46(1-2):177-81.
Parassitologia. 2004.

PMID: 15305712

Review.
Italian.

Moré G, Basso W, Bacigalupe D, Venturini MC, Venturini L.
Moré G, et al.
Parasitol Res. 2008 Mar;102(4):671-5. doi: 10.1007/s00436-007-0810-6. Epub 2007 Dec 8.
Parasitol Res. 2008.

PMID: 18066600

Related information

MedGen

LinkOut - more resources

Miscellaneous
NCI CPTAC Assay Portal

Format:

AMA

APA

MLA

NLM

Send To

Clipboard

Email
Save

My Bibliography
Collections

Citation Manager

[x]

NLM

NIH

HHS

USA.gov

An official website of the United States government

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.

The site is secure.

The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.

Three four-week-old calves were used in a study on serological responses in combined Sarcocystis cruzi and Toxoplasma gondii infections. One calf (C1) was inoculated orally with 100,000 S cruzi sporocysts, another (C2) with 40,000 sporocysts, while the third (C3) acted as uninfected control. One hundred and five days later, all three calves were inoculated orally with 100,000 T gondii oocysts. The antibody responses to sarcocystis and toxoplasma during 210 days were recorded, using different serological assays. During the S cruzi monoinfection phase, positive antibody reactions were recorded in C1 and C2, using an ELISA with soluble (cytoplasmic) T gondii tachyzoite antigen, while antibody reactions remained negative in the toxoplasma indirect fluorescent antibody test and in an ELISA employing T gondii tachyzoite cell membrane antigen. However, the Sabin Feldman dye test also showed transient low positive titres for C1 and C2 at around day 39 after S cruzi inoculation. When using an ELISA employing soluble S fusiformis cystozoite antigen, increased sarcocystis antibody counts were recorded for C1 and C2 starting two weeks after T gondii inoculation. Otherwise the three calves reacted as expected regarding the general antibody responses to the S cruzi and T gondii infections.

MeSH
PMC
Bookshelf
Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Help
Accessibility
Careers

Dashboard
Publications
Account settings
Log out

Journal List

PLoS One

PMC3114848

Create a new collection

Add to an existing collection

Unable to load your collection due to an error
Please try again

Published online 2011 Jun 14. doi: 10.1371/journal.pone.0020899

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, Georgia, United States of America

Wayne State University, United States of America
Received 2011 Mar 31; Accepted 2011 May 12.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
GUID: 5CE97979-5B88-4A17-A97E-8A2DBD13372E
1. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, et al. The LKB1 tumorsuppressor negatively regulates mTOR signaling. Cancer Cell. 2004; 6 :91–99. [ PubMed ] [ Google Scholar ]
2. Makowski L, Hayes DN. Role of LKB1 in lung cancer development. Br J Cancer. 2008; 99 :683–688. [ PMC free article ] [ PubMed ] [ Google Scholar ]
3. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008; 455 :1069–1075. [ PMC free article ] [ PubMed ] [ Google Scholar ]
4. Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008; 372 :449–456. [ PubMed ] [ Google Scholar ]
5. Abraham RT, Gibbons JJ. The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy. Clin Cancer Res. 2007; 13 :3109–3114. [ PubMed ] [ Google Scholar ]
6. Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther. 2008; 7 :1851–1863. [ PubMed ] [ Google Scholar ]
7. Konstantinidou G, Bey EA, Rabellino A, Schuster K, Maira MS, et al. Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations. Cancer Res. 2009; 69 :7644–7652. [ PMC free article ] [ PubMed ] [ Google Scholar ]
8. Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med. 2008; 14 :1351–1356. [ PMC free article ] [ PubMed ] [ Google Scholar ]
9. Wang X, Yue P, Kim YA, Fu H, Khuri FR, et al. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation. Cancer Res. 2008; 68 :7409–7418. [ PMC free article ] [ PubMed ] [ Google Scholar ]
10. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, et al. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res. 1997; 57 :4931–4939. [ PubMed ] [ Google Scholar ]
11. Wang X, Hawk N, Yue P, Kauh J, Ramalingam SS, et al. Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy. Cancer Biol Ther. 2008; 7 :1952–1958. [ PMC free article ] [ PubMed ] [ Google Scholar ]
12. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst. 2004; 96 :1769–1780. [ PubMed ] [ Google Scholar ]
13. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, et al. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene. 1999; 18 :2357–2365. [ PubMed ] [ Google Scholar ]
14. Li Y, Yue P, Deng X, Ueda T, Fukunaga R, et al. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E. Neoplasia. 2010; 12 :848–855. [ PMC free article ] [ PubMed ] [ Google Scholar ]
15. Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, et al. Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition. Cancer Res. 2005; 65 :7052–7058. [ PubMed ] [ Google Scholar ]
16. Guertin DA, Sabatini DM. The pharmacology of mTOR inhibition. Sci Signal. 2009; 2 :pe24. [ PubMed ] [ Google Scholar ]
17. Huang S, Bjornsti MA, Houghton PJ. Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther. 2003; 2 :222–232. [ PubMed ] [ Google Scholar ]
18. Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007; 12 :9–22. [ PubMed ] [ Google Scholar ]
19. Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, et al. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res. 2008; 68 :8022–8030. [ PubMed ] [ Google Scholar ]
20. Wang X, Sun SY. Enhancing mTOR-targeted cancer therapy. Expert Opin Ther Targets. 2009; 13 :1193–1203. [ PMC free article ] [ PubMed ] [ Google Scholar ]
21. Sarbassov dos D, Ali SM, Sengupta S, Sheen JH, Hsu PP, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006; 22 :159–168. [ PubMed ] [ Google Scholar ]
Articles from PLOS ONE are provided here courtesy of PLOS
1. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, et al. The LKB1 tumorsuppressor negatively regulates mTOR signaling. Cancer Cell. 2004; 6 :91–99. [ PubMed ] [ Google Scholar ] [ Ref list ]
2. Makowski L, Hayes DN. Role of LKB1 in lung cancer development. Br J Cancer. 2008; 99 :683–688. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
3. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008; 455 :1069–1075. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
4. Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008; 372 :449–456. [ PubMed ] [ Google Scholar ] [ Ref list ]
5. Abraham RT, Gibbons JJ. The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy. Clin Cancer Res. 2007; 13 :3109–3114. [ PubMed ] [ Google Scholar ] [ Ref list ]
6. Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther. 2008; 7 :1851–1863. [ PubMed ] [ Google Scholar ] [ Ref list ]
7. Konstantinidou G, Bey EA, Rabellino A, S
Худая девушка в чулках показывает бритую вагину
Пожилая развлекает себя секс игрушкой
Довольную невесту делят между собой два мужчины давая ей понять кайф двойного проникновения

Галерея 3114848

Report Page